FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely pirfenidone 801 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely pirfenidone 267 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely pirfenidone 267 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely stiripentol 500 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely stiripentol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only pirfenidone in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely stiripentol 250 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely stiripentol 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Lenalidomide 20 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Lenalidomide 20 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Lenalidomide 2.5 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Lenalidomide 2.5 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lenalidomide 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Lenalidomide 15 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Lenalidomide 15 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely erdosteine 300 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely erdosteine 300 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only erdosteine in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lenvatinib (as lenvatinib mesilate) 10 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely lenvatinib (as lenvatinib mesilate) 4 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only bromhexine (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Bromhexine only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely dabigatran etexilate (as dabigatran etexilate mesilate) 110 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing only meloxicam in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Neisseria meningitidis serogroup B antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Neisseria meningitidis antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Product containing only amisulpride in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Yellow fever virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Rimegepant only product Count of base of active ingredient False un Inferred relationship Some
    Product containing only rimegepant in oral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Rabies lyssavirus antigen Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in cellular line (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Rabies lyssavirus antigen grown in brain tissue (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Rotavirus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Product containing only isatuximab (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Isatuximab only product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Bacillus anthracis antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Human papillomavirus 16 and 18 antigens (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Human papillomavirus 6, 11, 16 and 18 antigens only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Junin virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vibrio cholerae antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Influenza virus antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Human papillomavirus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Streptococcus pneumoniae antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vibrio cholerae antigen only vaccine product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Lasmiditan 50 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Lasmiditan 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only inactivated whole Hepatitis A virus antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Live attenuated Salmonella enterica subspecies enterica serovar Typhi antigen only vaccine product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide unconjugated antigen only vaccine product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Clostridium tetani toxoid antigen (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Live attenuated Human poliovirus serotypes 1 and 3 antigens only vaccine product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only live attenuated Human poliovirus serotypes 1, 2, and 3 antigens in parenteral dose form (medicinal product form) Count of base of active ingredient False un Inferred relationship Some
    Bacillus Calmette-Guerin antigen only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Haemophilus influenzae type b capsular polysaccharide antigen conjugated only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Bacillus Calmette-Guerin antigen only vaccine product in parenteral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing only osilodrostat (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Osilodrostat only product in oral dose form Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely osilodrostat (as osilodrostat phosphate) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator value False un Inferred relationship Some 1
    Product containing precisely osilodrostat (as osilodrostat phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely osilodrostat (as osilodrostat phosphate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Osilodrostat (as osilodrostat phosphate) 10 mg oral tablet Count of base of active ingredient False un Inferred relationship Some
    Osilodrostat (as osilodrostat phosphate) 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria lineage antigens only vaccine product Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only Streptococcus pneumoniae capsular polysaccharide antigen conjugated (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) Count of base of active ingredient False un Inferred relationship Some
    Ibrutinib 140 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Ibrutinib 140 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely nitisinone 20 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Minoxidil 50 mg/mL cutaneous solution Count of base of active ingredient False un Inferred relationship Some
    Minoxidil 50 mg/mL cutaneous solution Has concentration strength denominator value False un Inferred relationship Some 1
    Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely midostaurin 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely palbociclib 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Palbociclib 75 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Palbociclib 75 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely palbociclib 125 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely panobinostat (as panobinostat lactate) 15 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Panobinostat (as panobinostat lactate) 10 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Panobinostat (as panobinostat lactate) 10 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False un Inferred relationship Some
    Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Eliglustat (as eliglustat tartrate) 84 mg oral capsule Count of base of active ingredient False un Inferred relationship Some
    Eliglustat (as eliglustat tartrate) 84 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1

    Start Previous Page 208 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start